Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease | American Society of Nephrology
Time course of serum creatinine and free light chains lambda for... | Download Scientific Diagram
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease | American Society of Nephrology
Removal of free light chains in hemodialysis patients without multiple myeloma: a crossover comparison of three different dialyzers | BMC Nephrology | Full Text
The biology of immunoglobulin free light chains and kidney injury - ScienceDirect
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Efficient Removal of Immunoglobulin Free Light Chains by Hemodialysis for Multiple Myeloma: In Vitro and In Vivo Studies | American Society of Nephrology
Physiology of serum free light chains - Renal Fellow Network
The biology of immunoglobulin free light chains and kidney injury - ScienceDirect
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
The biology of immunoglobulin free light chains and kidney injury - ScienceDirect
Serum Free Light Chain Assay - Renal Fellow Network
Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy | PLOS ONE
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure | BMC Nephrology | Full Text
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
View Image
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
JCM | Free Full-Text | Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients
Serum Free Light Chains and the Risk of ESRD and Death in CKD Article
Curing Cast Nephropathy by Removing Not-so-light Chains? — NephJC
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Manni Mohyuddin on Twitter: "Well- Normally kappa FLC are produced more often than lambda.. BUT lambda more frequently forms dimers, which doubles their molecular weight and slows their renal clearance..." / Twitter
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
